JAY VENKATESAN

Profile

First Name

: JAY

Middle Name

:

Last Name

: VENKATESAN

Related Companies
Titles
Company Name
Related People
DIRECTOR
LION BIOTECHNOLOGIES, INC.
IBRAHIM ABOTALEB, MARK J. AHN, DR. WILLIAM ANDREWS, ROBERT T. BROOKE, ANTHONY CATALDO, DR. L. STEPHEN COLES, MARIA FARDIS, STEVEN A. FISCHKOFF, MICHAEL HANDELMAN, MOLLY C. HENDERSON, SANFORD HILLSBERG, SANFORD J, HILLSBERG, PAUL KESSLER, GERALD LEWIS, MICHAEL T. LOTZE, RYAN MAYNARD, RICHARD MCKILLIGAN, MERRILL MCPEAK, MERRILL A. MCPEAK, WAYNE ROTHBAUM, MARTIN SCHROEDER, MANISH SINGH, DAVID VOYTICKY
DIRECTOR
AURASENSE THERAPEUTICS, LLC
DAVID A. GILJOHANN, HELEN S. KIM, CHAD A. MIRKIN, DAVID S. SNYDER, C. SHAD THAXTON, PERCY VAN CROCKER, JR., JAY R. VENKATESAN, DAVID WALT, DAVID R. WALT
EXECUTIVE OFFICER
ONCOTHYREON INC.
GARY CHRISTIANSON, JULIA EASTLAND, JULIA MARIE EASTLAND, DIANA HAUSMAN, CHRISTOPHER HENNEY, CHRISTOPHER S. HENNEY, RICHARD JACKSON, RICHARD L. JACKSON, SHASHI K. KARAN, ROBERT L. KIRKMAN, TED W. LOVE, SCOTT PETERSON, DANIEL SPIEGELMAN, DANIEL K. SPIEGELMAN, W. VICKERY STOUGHTON, DOUGLAS WILLIAMS
EXECUTIVE OFFICER, DIRECTOR
ALPINE IMMUNE SCIENCES, INC.
DR. MITCHELL H GOLD, MITCHELL H. GOLD, MICHAEL KORNACKER, DAVID MILLER, STANFORD PANG, J. PAUL RICKEY, RYAN SWANSON, PETER THOMPSON, JAMES TOPPER
DIRECTOR
TRANSPLANT GENOMICS INC.
MICHAEL ABECASSIS, ROY FIRST, KYLE HART, BRETT JENSEN, DAVID KRAVITZ, DARREN LEE, PETER LEWIS, CHRIS O-CONNOR, DIERDRE PIERRY, STANLEY ROSE, DANIEL SALOMON, DANIEL SOLOMON
EXECUTIVE OFFICER, DIRECTOR
ANGION BIOMEDICA CORP.
JULIAN ADAMS, CAROL ASHE, YEKATERINA CHUDNOVSKY, ROBERT CONNELLY, PETER DEMUTH, VICTOR GANZI, ITZHAK D. GOLDBERG, CHRISTOPHER HAQQ, ALLEN NISSENSON, GIL OMENN, BRIAN PIEKOS, ROBERT RUFFOLO, JAY R. VENKATESAN, KAREN WILSON, MICHAEL YAMIN
DIRECTOR
TIVORSAN PHARMACEUTICALS, INC.
JOEL BRAUNSTEIN, JAMES CONNOLLY, JUSTIN FALLON, MICHAEL MEYERS, JOHN NICHOLSON
DIRECTOR
ALPINE IMMUNE SCIENCES, INC.
ROBERT CONWAY, HOWARD FURST, MITCHELL GOLD, ZELANNA GOLDBERG, NATASHA HERNDAY, JONATHAN LEFF, MARK JAMES LITTON, EVAN LOH, JOSEPH LOSCALZO, JOHN MOORE, CHRISTOPHER PEETZ, STANFORD PENG, JAMES PAUL RICKEY, PAUL SEKHRI, TOM SOKOLOWSKI, PETER THOMPSON, JAMES TOPPER, CUI XIANGMIN
EXECUTIVE OFFICER, DIRECTOR
ELICIO THERAPEUTICS, INC.
JULIAN ADAMS, CAROL ASHE, YEKATERINA CHUDNOVSKY, ROBERT CONNELLY, PETER DEMUTH, VICTOR GANZI, ITZHAK D. GOLDBERG, CHRISTOPHER HAQQ, ALLEN NISSENSON, GIL OMENN, BRIAN PIEKOS, ROBERT RUFFOLO, JAY R. VENKATESAN, KAREN WILSON, MICHAEL YAMIN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-03-19 
2024-01-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-12-22 
2021-09-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-09-17 
2020-08-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-28 
2019-01-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-01-18 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-12 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-17 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-12 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-23 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-07-17 
2018-10-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-01-29 
2018-09-06
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-24 
2018-07-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-01-11 
2018-07-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-07-05 
2017-07-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-24 
2017-04-05
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-22 
2016-06-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-10 
2016-06-15
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2016-06-02 
2014-08-15
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2014-08-08 
2014-06-26
D
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2014-06-13 
2013-11-15
D
Link
BIOTECHNOLOGY 
ARRANGEMENT OF TRANSPORTATION OF FREIGHT + CARGO [4731] 
DECLINE TO DISCLOSE 
Equity 
2013-11-05